Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature (London), 2022-03, Vol.603 (7902), p.679-686 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04411-y ;PMID: 35042229Full text available |
|
2 |
Material Type: Article
|
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited seraNature medicine, 2021-04, Vol.27 (4), p.620-621 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. part of Springer Nature 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01270-4 ;PMID: 33558724Full text available |
|
3 |
Material Type: Article
|
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 VaccinationClinical infectious diseases, 2021-12, Vol.73 (11), p.2065-2072 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab381 ;PMID: 33906236Full text available |
|
4 |
Material Type: Article
|
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19Nature immunology, 2020-11, Vol.21 (11), p.1336-1345 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-020-0782-6 ;PMID: 32887977Full text available |
|
5 |
Material Type: Article
|
Myocarditis With COVID-19 mRNA VaccinesCirculation (New York, N.Y.), 2021-08, Vol.144 (6), p.471-484 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.121.056135 ;PMID: 34281357Full text available |
|
6 |
Material Type: Article
|
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteCell host & microbe, 2021-05, Vol.29 (5), p.819-833.e7 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.005 ;PMID: 33789084Full text available |
|
7 |
Material Type: Article
|
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationThe New England journal of medicine, 2021-01, Vol.384 (1), p.80-82 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2032195 ;PMID: 33270381Full text available |
|
8 |
Material Type: Article
|
T cell responses to SARS-CoV-2 spike cross-recognize OmicronNature (London), 2022-03, Vol.603 (7901), p.488-492 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 17, 2022 ;The Author(s) 2022, corrected publication 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04460-3 ;PMID: 35102311Full text available |
|
9 |
Material Type: Article
|
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021-01, Vol.29 (1), p.44-57.e9 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.007 ;PMID: 33259788Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of clinical microbiology, 2020-05, Vol.58 (6) [Peer Reviewed Journal]Copyright © 2020 American Society for Microbiology. ;Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology ;ISSN: 0095-1137 ;EISSN: 1098-660X ;DOI: 10.1128/jcm.00461-20 ;PMID: 32229605Full text available |
|
11 |
Material Type: Article
|
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7Cell reports (Cambridge), 2021-06, Vol.35 (13), p.109292-109292, Article 109292 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.109292 ;PMID: 34166617Full text available |
|
12 |
Material Type: Article
|
Antibody evasion by the P.1 strain of SARS-CoV-2Cell, 2021-05, Vol.184 (11), p.2939-2954.e9 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.055 ;PMID: 33852911Full text available |
|
13 |
Material Type: Article
|
An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportNew England Journal of Medicine, 2020-11, Vol.383 (20), p.1920-1931 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2022483 ;PMID: 32663912Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike GlycoproteinCell, 2020-04, Vol.181 (2), p.281-292.e6 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.02.058 ;PMID: 32155444Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2Nature (London), 2022-02, Vol.602 (7898), p.676-681 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04388-0 ;PMID: 35016198Full text available |
|
16 |
Material Type: Article
|
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralizationNature (London), 2022-02, Vol.602 (7898), p.654-656 [Peer Reviewed Journal]2021. The Author(s). ;Copyright Nature Publishing Group Feb 24, 2022 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04387-1 ;PMID: 35016196Full text available |
|
17 |
Material Type: Article
|
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in RussiaThe Lancet (British edition), 2021-02, Vol.397 (10275), p.671-681 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00234-8 ;PMID: 33545094Full text available |
|
18 |
Material Type: Article
|
Cell entry mechanisms of SARS-CoV-2Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (21), p.11727-11734 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences May 26, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2003138117 ;PMID: 32376634Full text available |
|
19 |
Material Type: Article
|
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine seraCell, 2021-04, Vol.184 (8), p.2201-2211.e7 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 The Authors 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.02.033 ;PMID: 33743891Full text available |
|
20 |
Material Type: Article
|
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variantsNature communications, 2021-11, Vol.12 (1), p.6977-6977, Article 6977 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27325-1 ;PMID: 34848718Full text available |